Search

Your search keyword '"Chang-Claude, J. (Jenny)"' showing total 78 results

Search Constraints

Start Over You searched for: Author "Chang-Claude, J. (Jenny)" Remove constraint Author: "Chang-Claude, J. (Jenny)"
78 results on '"Chang-Claude, J. (Jenny)"'

Search Results

1. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

2. Rare germline copy number variants (CNVs) and breast cancer risk

3. CYP3A7*1C allele:linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

4. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

5. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

6. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis

7. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

8. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

9. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

10. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

11. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

12. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

13. Genome-wide association study of germline variants and breast cancer-specific mortality

14. Erratum: Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature communications (2019) 10 1 (431))

15. Shared heritability and functional enrichment across six solid cancers

16. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

17. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes

18. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

19. Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation

20. E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium

21. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

22. The BRCA2 c.68‐7T > A variant is not pathogenic:a model for clinical calibration of spliceogenicity

23. Body mass index and breast cancer survival:a Mendelian randomization analysis

24. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

25. Genetic modifiers of CHEK2∗1100delC-associated breast cancer risk

26. Body mass index and breast cancer survival

27. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

28. Reproductive profiles and risk of breast cancer subtypes

29. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

30. PHIP:a novel candidate breast cancer susceptibility locus on 6q14.1

31. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

32. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

33. Age-And tumor subtype-specific breast cancer risk estimates for CHEK2∗1100delC Carriers

34. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

35. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

36. Prognostic value of automated KI67 scoring in breast cancer: A centralised evaluation of 8088 patients from 10 study groups

37. High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium (BCAC)

38. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

39. Genetic predisposition to ductal carcinoma in situ of the breast

40. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

41. Fine-mapping of the 1p11.2 breast cancer susceptibility locus

42. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

43. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

44. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

45. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1

46. Prediction of breast cancer risk based on profiling with common genetic variants

47. A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients

48. Identification of novel genetic markers of breast cancer survival

49. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

50. Common germline polymorphisms associated with breast cancer-specific survival

Catalog

Books, media, physical & digital resources